Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/1991
08/27/1991US5043328 Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
08/27/1991US5043160 Treatment of diarrhoea with compositions derived from carob pod
08/27/1991US5043153 Using plant extracts
08/27/1991CA1288100C 1-(hydroxymethyl)-1,6,7,11b-tetrahydro-2h,4h-[1,3]- oxazino- or thiazino-[4,5-a]-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containingthem
08/22/1991WO1991012253A1 Tetralin and chroman derivatives useful in the treatment of asthma, arthritis, and related diseases
08/21/1991EP0442394A2 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
08/20/1991WO1991012265A1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them
08/20/1991US5041557 Antiulcer agents
08/20/1991US5041456 Pharmaceutically useful 3-(indol-3-yl)-1,2,4-oxa- and thiadiazoles substituted in the 5-position by an amino containing group
08/20/1991US5041440 Dithiolane derivatives
08/20/1991CA2069087A1 N-phenyl n-alcoxycarbonylalkylglycinamides, their preparation and medicaments containing them
08/20/1991CA1287802C Pharmaceutical formulation containing cimetidine
08/14/1991EP0441515A1 Tetralin and chroman derivatives in the treatment of asthma, arthritis and related diseases
08/14/1991EP0440693A1 Gynaecological procedure
08/14/1991EP0302896B1 N-(w-substituted alkyl)-n'-[(imidazole-4-yl)alkyl]guanidine
08/13/1991US5039808 Therapeutically active cyclopropyl substituted compound
08/13/1991US5039806 Antisecretory and antiulcer agents
08/13/1991US5039699 Anti-peptic ulcer agent
08/13/1991US5039691 5-(1-(imidazol)methyl)-3,3-disubstituted-2(3H)furanone derivatives
08/08/1991CA2035626A1 Tetralin and chroman derivatives in the treatment of asthma, arthritis and related diseases
08/07/1991EP0440324A2 Substituted beta-diketones and their use
08/07/1991EP0439513A1 Composition for inhibiting transmission of aids.
08/07/1991CN1013442B Bicyclic compound processes for prepn. thereof and pharmaceutical composition comprising same
08/06/1991US5037844 Substituted 1H-indazole-3-carboxamides
08/06/1991US5037837 5-lipoxygenase inhibitor
08/06/1991US5037830 Antisecretory-antiulcer agents
08/06/1991US5037634 A bicarbonate salt and a complexing agent; toothpaste, gel, mouthwash or rinse
08/06/1991US5037633 Microbiologically stabilized phase for bicarbonate toothpaste manufacture
08/01/1991WO1991011510A1 Lactobacillus acidophilus f-133, lactic acid bacterium preparation prepared therefrom, and process for preparing the same
08/01/1991CA2049313A1 Lactobacillus acidophilus f-133, lactic acid bacteria preparations using the same and a process of manufacturing the preparations
07/1991
07/31/1991EP0439174A2 Inhibition of gut endothelium ion-secretion by peptide derivatives
07/31/1991EP0438533A1 Muscarinic receptor antagonists
07/31/1991EP0438519A1 Therapeutic peptides
07/30/1991US5036097 Antiinflammatory agents/non-steriodal
07/30/1991US5035899 Benzimidazole antiulcer agents, protective coatings on tablets, stabilization
07/30/1991US5035882 Piperine, cough medicine, mouth washes, toostepastes
07/24/1991EP0438146A2 Interleukin-1-beta for treating ulcers
07/24/1991EP0437790A2 Antithrombotic compounds
07/24/1991CN1053183A Stable oral zinc compound
07/23/1991US5034419 N-cycloalkylalkylamines, process for their preparation, their use as medicament and their synthesis intermediates
07/23/1991US5034398 1H-indazole-3-carboxamide-N-2-azabicyclo[2.2.2]octanes useful for treating anxiety, psychosis, neuralgia, migraine and cluster headaches
07/23/1991US5034394 Treatment of aids-HIV or HBV infections
07/23/1991CA1286669C Aminoalkylphenoxy derivatives
07/23/1991CA1286668C Imidazo[1,2-a]quinoline derivatives, their preparation and their application in therapy
07/23/1991CA1286623C Liver function-improving agent and blood pressure- lowering agent
07/20/1991WO1991010659A1 Oxathiane derivatives
07/20/1991CA2074173A1 Oxathiane derivatives
07/20/1991CA2034520A1 Pharmaceutical composition for protecting the gastroduodenal mucosa
07/18/1991DE4001323A1 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln 2,13-disubstituted ergoline, their production and use in medicinal products
07/16/1991WO1991010663A1 2,13-disubstituted ergolins, their preparation and their use in drugs
07/16/1991US5032585 Antiulcer, respiratory system disorders
07/16/1991US5032399 Gastrointestinal side effect reduction of antibiotic therapy, Lactobacillus
07/16/1991US5032393 Ranitidine flavor masking
07/16/1991US5032384 Tocopherol and ketoprofen, peridontal diseases
07/16/1991CA2049016A1 2,13-disubstituted ergolines, their production and use in pharmaceutical agents
07/12/1991CA2020772A1 Natural intense sweeteners
07/11/1991WO1991009846A1 New dihydropyridines
07/11/1991WO1991009608A1 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
07/11/1991WO1991009593A2 5-ht3 antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability
07/10/1991EP0436435A1 Phenylethanolaminomethyltetralins, procedure for their preparation and pharmaceutical compositions containing same
07/10/1991EP0436398A1 Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity
07/10/1991EP0436284A1 Stable oral composition of zinc
07/10/1991EP0436061A1 Bowel lavage composition
07/10/1991EP0435996A1 MODIFIED TRANSFORMING GROWTH FACTOR $g(a) OLIGOPEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF
07/10/1991CN1052777A Multiple encapsulated sweetener delivery system and method of preparation
07/09/1991WO1991010652A1 Thioformamide derivatives
07/09/1991US5030646 Treatment of diseases resulting from disfunction of seretoninergic system
07/09/1991CA2073240A1 Thioformamide derivatives
07/07/1991WO1991010654A1 Muscarinic receptor antagonists
07/07/1991WO1991010650A1 Piperidine and pyrrolidine derivatives
07/07/1991WO1991010648A1 Diphenylsulphoximine muscarinic receptor antagonists
07/07/1991WO1991010647A1 Muscarinic receptor antagonists
07/07/1991CA2072127A1 Diphenylsulphoximine muscarinic receptor antagonists
07/04/1991CA2029330A1 Stable oral composition of zinc
07/03/1991EP0435362A1 Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline
07/03/1991EP0435134A2 LTB4 Synthesis inhibitors
07/03/1991EP0434979A1 Peptide derivatives useful as antagonists of bombesin and gastrin-releasing peptide
07/03/1991EP0434722A1 New pentapeptide and a process for the preparation thereof
07/03/1991CN1052670A Therapeutically active fluoro substituted benzimidazoles process for their preparation as well as their use
07/03/1991CN1052668A Compounds for treating inflammatory bowel disease
07/03/1991CN1052664A Antithrombotic compounds
07/02/1991CA1285491C Method of treating catabolic dysfunction
06/1991
06/30/1991CA2222658A1 Intermediates in preparation of new phenylethanolaminomethyltetralins
06/26/1991EP0434394A2 Compounds for treating inflammatory bowel disease
06/26/1991EP0434369A1 New benzodiazepine analogs
06/26/1991EP0434360A1 New benziodiazepine analogs
06/26/1991EP0434321A2 Multiple encapsulated sweetener delivery system and method of preparation
06/26/1991EP0434202A1 Azabicyclo amides and esters as 5-HT3 receptor antagonists
06/26/1991CN1052480A Thiazolidone derivatives, pharmaceutical compositions containing them and process for preparing same
06/25/1991US5026883 Used for pharmaceutical, dietary or cosmetic purposes
06/25/1991US5026858 Used for treating nausea, vomating, gastrointestinal disorders and centarl nervous system
06/25/1991US5026715 2-guanidino-4-arylthiazoles for treatment of peptic ulcers
06/25/1991US5026699 Use of 5,11-dihydro-6H-pyrido[2,3-b][1,4]-benzodiazepin-6-ones substituted in the 11-position for treating bradycardia and bradyarrhythmia in human and veterinary medicine
06/23/1991WO1991009597A1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
06/23/1991CA2072010A1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
06/22/1991CA2071994A1 Pharmaceuticals
06/21/1991WO1991009028A1 Therapeutically active fluoro substituted benzimidazoles, processes for their preparation as well as their use
06/21/1991CA2070651A1 Therapeutically active fluoro substituted benzimidazoles, processes for their preparation as well as their use
06/19/1991EP0432254A1 NUCLEIC ACID CODING FOR THE HUMAN TESTICULAR ANGIOTENSIN CONVERSION ENZYME (ECA) AND ITS APPLICATIONS, IN PARTICULAR FOR THE $i(IN VITRO) DETECTION OF SAID ENZYME IN THE ORGANISM
06/19/1991CN1052305A Pyridine derivatives, pharmaceutical compositions containing them and process for preparing same